Key Highlights

  • Ryman Healthcare reports its first positive free Cash Flow result in over a decade at NZ$188 million in FY26, underpinned by cash release from developments and improved operational performance, with EBITDAF up 94% to NZ$88 million
  • Operating Revenue grows 10% to NZ$849 million driven by new aged care capacity filling, growth in aged care premiums, and a growing proportion of retirement living residents on new pricing terms — all structural rather than cyclical improvements
  • Balance Sheet reset complete with lowest-in-sector gearing of 27.8%, no bank maturities until FY31, and a clear pathway to resuming dividends in FY28, subject to operating performance and Board approval

 

 

Ryman Healthcare Limited (ASX:RYM) has released its FY26 annual results for the year ended 31 March 2026, delivering what management characterises as a significant year of progress toward its strategic priorities. The headline achievement is the company's first positive free cash flow result in more than a decade, generating NZ$188 million — a milestone that marks the conclusion of an intensive two-year operational and financial reset and the beginning of what management describes as a more sustainable trajectory for the Business.

Operating EBITDAF grew 94% to NZ$88 million, driven by improved aged care occupancy, premium growth, and cost efficiencies across the portfolio. Loss before tax and Fair Value movements per share narrowed sharply to -7.2 cents per share from -54.1 cents per share in FY25, a NZ$312 million improvement in a single year. These are not incremental improvements — they represent the compound effect of the strategic, operational, and financial resets Ryman has been executing since FY24.

Free Cash Flow: Why This Milestone Matters

Ryman Healthcare is a retirement village and aged care operator with a portfolio spanning New Zealand and Australia, structured around an Occupation Right Agreement model in the retirement living segment and direct-care provision in aged care. The business model is inherently Capital-intensive, and for much of the past decade, Ryman's aggressive development programme outstripped its operational cash generation, resulting in persistent negative free cash flow that required ongoing Debt funding. The shift to NZ$188 million positive free cash flow in FY26 is therefore not merely a financial metric but a structural statement about the maturation of the business model.

The cash generation was underpinned by two sources: NZ$150 million net cash flow released from developments, and NZ$72 million in proceeds from settled land divestments. The land divestment programme — now targeting total proceeds of approximately NZ$250 million by FY29, increased from NZ$200 million previously — has become an important complement to operational cash generation in the path to Ryman's FY29 targets.

EBITDAF Growth: Occupancy, Premiums, and Cost Discipline

The 94% growth in Operating EBITDAF to NZ$88 million was driven by three organic factors: new aged care capacity filling at improving rates, growth in aged care premiums, and an increasing number of retirement living residents on the new pricing terms introduced as part of the strategic reset. Together, these factors lifted Operating Revenue by 10% to NZ$849 million, providing the top-line growth that, combined with cost and procurement efficiencies, generated the substantial EBITDAF uplift.

Ryman has made NZ$47 million of progress toward its target of NZ$150 million in sustainable improvement to cash flow from existing operations by FY29. That represents approximately 31% of the FY29 target in a single year, and the trajectory suggests the company may achieve its target ahead of schedule if occupancy trends and pricing improvements are sustained. Aged care operating EBITDAF per bed reached NZ$17,700 in FY26, with FY27 guidance targeting NZ$20,000 to NZ$25,000 — a significant step toward the levels that would support adequate returns on the capital invested in the aged care portfolio.

Balance Sheet: Sector-Low Gearing and Long-Dated Debt

Ryman's balance sheet reset is now complete. Gearing stands at 27.8%, described by the company as the lowest in the retirement and aged care sector. A full refinance of bank facilities was completed during FY26, with improved pricing, financial covenants, and materially increased funding tenor — no bank maturities until FY31. The company is considering Options for its NZ$150 million retail bond maturing in December 2026 to maintain diversified sources of debt, a standard balance sheet management exercise.

The introduction of a new capital management framework at Ryman's February 2026 Investor Day provides a structured basis for future capital allocation decisions, including the pathway to reinstating dividends. The company has indicated that a return to sustainable dividends in FY28 is the target, subject to operating performance and Board approval. For investors who have held through the Dividend suspension period, the FY28 dividend pathway represents a meaningful near-term catalyst.

Market Conditions and FY27 Outlook

Current market conditions are described as mixed, with geopolitical tensions and elevated fuel prices creating economic uncertainty. Despite this, Demand for Ryman's care and serviced apartments has grown year-to-date on the prior corresponding period, reflecting what the company characterises as needs-based demand independent of broader economic sentiment. Retirement living ORA resales and net contracts year-to-date in FY27 are described as broadly flat on the prior period, with serviced apartments making up a higher proportion of the mix.

FY27 guidance reflects a deliberate moderation in development activity, with build rate guided to 157 to 168 units and beds (versus 330 in FY26) and capex guided to NZ$150 to $180 million (versus NZ$221.8 million in FY26). The reduction in development activity is designed to focus the organisation on maximising returns from the existing portfolio and releasing cash from vacant stock, rather than adding new Supply before the current inventory is fully absorbed. This capital discipline is central to the path toward the FY29 financial targets.

Long-Term Demand Fundamentals

The aged care and retirement living sector in New Zealand and Australia faces a structural demographic tailwind that is both well-documented and largely inevitable. The 80-plus population is expected to double by 2050, creating persistent supply Scarcity relative to demand. Government acknowledgment of this dynamic — through aged care reform in both Australia and New Zealand — is translating into regulatory changes that support the operational environment for quality providers.

Conclusion

Ryman Healthcare's FY26 results mark the end of a two-year reset and the beginning of a more financially sustainable phase for the business. Positive free cash flow after more than a decade, a 94% EBITDAF uplift, sector-lowest gearing, and a visible pathway to dividend reinstatement in FY28 collectively represent a fundamental improvement in the Investment profile of the company. The FY27 guidance framework — with deliberately moderated development activity, improving aged care Earnings per bed, and continued cash release from inventory — positions Ryman to build on FY26 momentum rather than absorb it through renewed capital intensity.